Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects.

Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects.

Item
http://www.wikidata.org/entity/Q47448168
Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseasePharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.Oral heparin: status reviewTinzaparin: considerations for use in clinical practice.Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion.Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during haemodialysis.Analysis of the protein-protein interaction networks of differentially expressed genes in pulmonary embolism.Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.The Role of Tinzaparin in Oncology.
P2860

Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects.

Item
http://www.wikidata.org/entity/Q47448168
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pharmacodynamic properties of ...... tor in healthy human subjects.
@en
Pharmacodynamic properties of ...... tor in healthy human subjects.
@nl
type
label
Pharmacodynamic properties of ...... tor in healthy human subjects.
@en
Pharmacodynamic properties of ...... tor in healthy human subjects.
@nl
prefLabel
Pharmacodynamic properties of ...... tor in healthy human subjects.
@en
Pharmacodynamic properties of ...... tor in healthy human subjects.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Pharmacodynamic properties of ...... tor in healthy human subjects.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921